Utilizing RNAs for in vivo drug discovery

We are harnessing RNA payloads (RNAi, mRNA, saRNA, and cirRNA) as in vivo tools for drug discovery.

Nucleic acids loaded lipid nanoparticles have emerged as a promising therapeutic approach for various malignancies, rare genetic diseases, and inflammation. We aim to utilize RNA-loaded lipid nanoparticles to identify in vivo (in their biological environment) new potential drug targets that could be then applied to therapeutics in various malignancies, including head & neck cancer, glioblastoma, blood cancers, breast cancer, rare genetic diseases, and inflammation-related diseases such as inflammatory bowel diseases (IBD).